The Competition Bureau announced that it reached an agreement with Evonik Industries to address competition concerns related to its proposed acquisition of PeroxyChem.
Following an extensive review, the Bureau concluded that Evonik’s acquisition of PeroxyChem was likely to result in a substantial lessening of competition in the supply of hydrogen peroxide in Western Canada.
To remedy this concern, Evonik has agreed to sell PeroxyChem’s hydrogen peroxide manufacturing facility located in Prince George, British Columbia and related assets to a buyer acceptable to the Commissioner of Competition.
Under the agreement registered with the Competition Tribunal, Evonik has proposed United Initiators (UI) as the buyer of this facility. The Commissioner reviewed UI’s suitability and concluded that they are an acceptable buyer.
The Bureau is satisfied that this agreement will preserve competition in Western Canada’s hydrogen peroxide market.
Full Content: Canada
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Colorado Makes History: First State to Enact Comprehensive AI Legislation
May 14, 2024 by
CPI
Class Action Settlement Reached in Cheerleading Monopoly
May 14, 2024 by
CPI
DOJ Nears Antitrust Lawsuit Against Live Nation
May 14, 2024 by
CPI
Chile Proposes Legislation to Regulate Artificial Intelligence
May 14, 2024 by
CPI
Proposed NCAA Antitrust Settlement in the Works, Says Attorney
May 14, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI